Clinical significance of neoadjuvant chemotherapy for locally advanced colorectal cancer patients with deficient mismatch repair: possibly residual value in the era of immunotherapy.

Therapeutic advances in gastroenterology(2023)

引用 0|浏览12
暂无评分
摘要
In this study, NAC was associated with better tumor downstaging and longer 5-year DFS in LACC patients with dMMR. Consequently, NAC might be an additional treatment choice when it comes to such patients in the future.
更多
查看译文
关键词
deficient mismatch repair,locally advanced colorectal cancer,neoadjuvant chemotherapy,prognosis
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要